Table 4.
Q1 | Q2 | Q3 | Q4 | p Trend | |
---|---|---|---|---|---|
Levels of SIRI | <0.68 | 0.68–0.98 | 0.99–1.42 | >1.43 | |
Cardiovascular mortality | |||||
No. deaths/total | 177/10,684 | 181/10,732 | 246/10,725 | 394/10,734 | |
Crude | Reference | 0.98 (0.80–1.21) | 1.35 (1.12–1.64) | 2.26 (1.89–2.70) | <0.001 |
Model 1 | Reference | 0.90 (0.73–1.12) | 1.18 (0.96–1.44) | 1.60 (1.32–1.94) | <0.001 |
Model 2 | Reference | 0.88 (0.71–1.09) | 1.10 (0.90–1.34) | 1.39 (1.14–1.68) | <0.001 |
All-cause mortality | |||||
No. deaths/total | 737/10,684 | 851/10,732 | 1080/10,725 | 1582/10,734 | |
Crude | Reference | 1.11 (1.01–1.22) | 1.43 (1.30–1.57) | 2.18 (2.00–2.38) | <0.001 |
Model 1 | Reference | 1.01 (0.91–1.12) | 1.22 (1.11–1.35) | 1.57 (1.43–1.72) | <0.001 |
Model 2 | Reference | 0.99 (0.90–1.10) | 1.16 (1.05–1.28) | 1.39 (1.26–1.52) | <0.001 |
Data are presented as HR (95% CI) unless indicated otherwise.